跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle
Approved
STANDARD
PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle
Boucher & Muir Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jul 5, 2025
Approval ID
776523fb27999a59
Company
Boucher & Muir Pty Ltd
Type
Standard
Approval Details
Approval Id
776523fb27999a59
Product Name
PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle
Artg Id
447744
Artg Name
PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle
Sponsor
Boucher & Muir Pty Ltd
Company Detail Path
/organization/boucher-and-muir-pty-ltd
Artg Date
2025-07-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jul 5, 2025
Approval ID
776523fb27999a59
Type
Standard
Back to TGA Approvals
PAZOPANIB ADVZ pazopanib (as hydrochloride) 400 mg tablet bottle - TGA Drug Approval Details
